-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On April 1, Hainan Puli Pharmaceuticals issued an announcement that the company recently received a marketing authorization for ganciclovir for injection issued by the Italian Drug Administration (AIFA).
Ganciclovir (Ganciclovir) is a guanosine derivative, similar to acyclovir.
500mg ganciclovir for injection was applied by Roche Palo in June 1989 to be marketed in the United States under the trade name CYTOVENE®-IV.